$SGBX
SAFE & GREEN HOLDINGS CORP. Stock $sgbx

$sgbx Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000121390024040541 Filed on May 07, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue	$1.253M	$1.957M	$16.52M
YoY Change	-75.41%	-52.32%	-32.27%
Cost Of Revenue	$1.094M	$3.941M	$19.08M
YoY Change	-78.39%	-0.05%	-9.75%
Gross Profit	$159.2K	-$1.984M	-$2.556M
YoY Change	373.29%	-1333.13%	-178.56%
Gross Profit Margin	12.7%	-101.42%	-15.47%
Selling, General & Admin	$1.223M	$4.955M	$9.062M
YoY Change	-16.22%	24.84%	-13.23%
% of Gross Profit	768.53%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$42.30K	$140.1K	$370.5K
YoY Change	-54.26%	4.1%	-9.7%
% of Gross Profit	26.57%
Operating Expenses	$2.953M	$4.966M	$22.22M
YoY Change	-47.68%	24.77%	111.9%
Operating Profit	-$2.794M	-$6.950M	-$24.77M
YoY Change	-50.21%	82.0%	242.64%
Interest Expense	-$1.889M	-$1.081M	$2.609M
YoY Change	-460.58%	791.49%	-1094.09%
% of Operating Profit
Other Income/Expense, Net	-$1.754M	-$67.63K	-$1.985M
YoY Change	-3269.77%	12.83%	-1510.7%
Pretax Income	-$4.548M	-$14.07M	-$26.76M
YoY Change	-18.14%	249.67%	277.44%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$4.548M	-$13.60M	-$26.28M
YoY Change	-18.14%	264.31%	215.93%
Net Earnings / Revenue	-362.83%	-695.01%	-159.07%
Basic Earnings Per Share	-$2.73		-$34.03
Diluted Earnings Per Share	-$2.73	-$15.55	-$34.03
COMMON SHARES
Basic Shares Outstanding	1.218M shares	16.48M shares	772.3K shares
Diluted Shares Outstanding	1.412M shares		772.3K shares

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.017M	$17.45K	$17.45K
YoY Change	-36.5%	-97.01%	-97.01%
Cash & Equivalents	$1.017M	$17.45K	$17.45K
Short-Term Investments
Other Short-Term Assets	$4.080M	$1.902M	$4.973M
YoY Change	82.75%	-72.07%	-3.27%
Inventory	$223.4K	$156.5K	$156.5K
Prepaid Expenses
Receivables	$364.4K	$182.8K	$193.5K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$7.398M	$5.341M	$5.341M
YoY Change	-20.69%	-28.85%	-28.85%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.506M	$5.582M	$7.570M
YoY Change	-21.24%	-0.47%	-24.53%
Goodwill	$1.811M
YoY Change	38.3%
Intangibles	$557.3K	$23.62K
YoY Change	-72.09%	-98.82%
Long-Term Investments	$3.643M	$3.643M	$3.643M
YoY Change	-15.78%	-15.29%	-15.29%
Other Assets		$30.59K	$30.59K
YoY Change		-57.14%	-57.14%
Total Long-Term Assets	$13.53M	$11.87M	$11.87M
YoY Change	-27.01%	-37.68%	-37.68%
TOTAL ASSETS
Total Short-Term Assets	$7.398M	$5.341M	$5.341M
Total Long-Term Assets	$13.53M	$11.87M	$11.87M
Total Assets	$20.93M	$17.21M	$17.21M
YoY Change	-24.89%	-35.19%	-35.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.01M	$7.490M	$7.490M
YoY Change	42.4%	138.0%	86.81%
Accrued Expenses		$2.511M	$2.511M
YoY Change		499.82%	499.82%
Deferred Revenue	$1.737M	$1.367M
YoY Change	929.31%	212.62%
Short-Term Debt	$0.00	$8.472M	$8.472M
YoY Change	-100.0%	219.91%	219.91%
Long-Term Debt Due	$10.10M	$8.472M	$709.3K
YoY Change	1213.41%	950.11%	-12.08%
Total Short-Term Liabilities	$22.31M	$20.55M	$20.55M
YoY Change	47.67%	146.8%	146.8%
LONG-TERM LIABILITIES
Long-Term Debt	$2.462M	$2.592M	$2.592M
YoY Change	-18.85%	55.11%	55.11%
Other Long-Term Liabilities	$945.0K	$405.0K	$405.0K
YoY Change	138.03%	-80.89%	-80.89%
Total Long-Term Liabilities	$3.407M	$2.997M	$2.997M
YoY Change	-0.7%	-20.93%	-20.93%
TOTAL LIABILITIES
Total Short-Term Liabilities	$22.31M	$20.55M	$20.55M
Total Long-Term Liabilities	$3.407M	$2.997M	$2.997M
Total Liabilities	$25.72M	$23.55M	$24.67M
YoY Change	38.72%	94.34%	110.26%
SHAREHOLDERS EQUITY
Retained Earnings	-$84.46M	-$75.93M
YoY Change	67.24%	83.28%
Common Stock	$17.48K	$8.814K
YoY Change	-89.09%	-93.01%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$92.40K	$92.40K
YoY Change	0.0%	85.98%
Treasury Stock Shares
Shareholders Equity	-$9.134M	-$7.459M	-$7.459M
YoY Change
Total Liabilities & Shareholders Equity	$20.93M	$17.21M	$17.21M
YoY Change	-24.89%	-35.19%	-35.19%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$4.548M	-$13.60M	-$26.28M
YoY Change	-18.14%	264.31%	215.93%
Depreciation, Depletion And Amortization	$42.30K	$140.1K	$370.5K
YoY Change	-54.26%	4.1%	-9.7%
Cash From Operating Activities	-$3.694M	-$2.470M	-$7.142M
YoY Change	122.49%	3089.01%	26.84%
INVESTING ACTIVITIES
Capital Expenditures	-$65.08K	$172.2K	$607.4K
YoY Change	-312.26%	-79.29%	-77.99%
Acquisitions
YoY Change
Other Investing Activities	-$20.00	$0.00	-$42.66K
YoY Change		-100.0%	-95.84%
Cash From Investing Activities	$65.06K	-$172.2K	-$864.8K
YoY Change	-312.2%	-43.34%	-77.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			-$352.0K
YoY Change			-808.57%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.906M	1.947M	$7.441M
YoY Change	112.3%	-268.68%	-351.59%
NET CHANGE
Cash From Operating Activities	-3.694M	-2.470M	-$7.142M
Cash From Investing Activities	65.06K	-172.2K	-$864.8K
Cash From Financing Activities	3.906M	1.947M	$7.441M
Net Change In Cash	277.0K	-695.5K	-$565.3K
YoY Change	86.15%	-54.7%	-95.46%
FREE CASH FLOW
Cash From Operating Activities	-$3.694M	-$2.470M	-$7.142M
Capital Expenditures	-$65.08K	$172.2K	$607.4K
Free Cash Flow	-$3.629M	-$2.642M	-$7.749M
YoY Change	114.61%	190.63%	-7.65%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	us-gaap	Profit Loss ProfitLoss	-26757906	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	5532302	usd
CY2023	sgbx	Revenue Recognized Over Time RevenueRecognizedOverTime	16523080	usd
CY2023Q4	us-gaap	Finance Lease Liability Statement Of Financial Position Extensible List FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#FinanceLeaseLiability
CY2023	us-gaap	Restricted Cash And Cash Equivalent Item Description RestrictedCashAndCashEquivalentItemDescription	The event that the Agreement was earlier terminated, CMC was entitled to receive the entire amount of such restricted stock that had vested as of such earlier termination date, but in no event less than 1,250 shares of such restricted stock. The Agreement also provided for customary indemnification and confidentiality obligations between the parties. The 2,500 shares of restricted stock of the Company's common stock has yet to be issued to CMC.
CY2023	us-gaap	Operating Loss Carryforwards Expiration Date OperatingLossCarryforwardsExpirationDate	2037-12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001023994
CY2023	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-38037
CY2023	dei	Entity Registrant Name EntityRegistrantName	SAFE & GREEN HOLDINGS CORP.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	95-4463937
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	990 Biscayne Blvd.,
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	#501,
CY2023	dei	Entity Address Address Line3 EntityAddressAddressLine3	Office 12,
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Miami
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33132
CY2023	dei	City Area Code CityAreaCode	(646)
CY2023	dei	Local Phone Number LocalPhoneNumber	240-4235
CY2023	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2023	dei	Trading Symbol TradingSymbol	SGBX
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	13886538	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1218081	shares
CY2023	dei	Auditor Firm AuditorFirmId	726
CY2023	dei	Auditor Name AuditorName	Whitley Penn LLP
CY2023	dei	Auditor Location AuditorLocation	Dallas, Texas
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17448	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	582776	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	182753	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1280456	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	10745	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	36384	usd
CY2023Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	4400361	usd
CY2022Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	4396826	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	156512	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	465560	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	572779	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	744211	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	5340598	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	7506213	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5582401	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5608903	usd
CY2023Q4	sgbx	Project Development Costs And Other Non Current Assets ProjectDevelopmentCostsAndOtherNonCurrentAssets	604327	usd
CY2022Q4	sgbx	Project Development Costs And Other Non Current Assets ProjectDevelopmentCostsAndOtherNonCurrentAssets	483546	usd
CY2023Q4	us-gaap	Goodwill Goodwill		usd
CY2022Q4	us-gaap	Goodwill Goodwill	1309330	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1987137	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4421002	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent		usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	857534	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	23616	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1997833	usd
CY2023Q4	us-gaap	Deferred Costs DeferredCosts	30589	usd
CY2022Q4	us-gaap	Deferred Costs DeferredCosts	71374	usd
CY2023Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent		usd
CY2022Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	700000	usd
CY2023Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	3642607	usd
CY2022Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	3599945	usd
CY2023Q4	us-gaap	Assets Assets	17211275	usd
CY2022Q4	us-gaap	Assets Assets	26555680	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	9854263	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4009522	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1366998	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	437271	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	856088	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1225394	usd
CY2023Q4	us-gaap	Liabilities Of Business Transferred Under Contractual Arrangement Current LiabilitiesOfBusinessTransferredUnderContractualArrangementCurrent		usd
CY2022Q4	us-gaap	Liabilities Of Business Transferred Under Contractual Arrangement Current LiabilitiesOfBusinessTransferredUnderContractualArrangementCurrent	5795	usd
CY2023Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	8472080	usd
CY2022Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	2648300	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	20549429	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8326282	usd
CY2023Q4	us-gaap	Other Loans Payable Long Term OtherLoansPayableLongTerm	2447415	usd
CY2022Q4	us-gaap	Other Loans Payable Long Term OtherLoansPayableLongTerm	750000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	549290	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3039836	usd
CY2023Q4	us-gaap	Liabilities Liabilities	23546134	usd
CY2022Q4	us-gaap	Liabilities Liabilities	12116118	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	1
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5405010	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5405010	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	881387	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	814969	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	630699	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	607584	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	8814	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	6307	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	68555050	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	56293810	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	3371	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1155	shares
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	92396	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	49680	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-75930805	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-41428268	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-7459337	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	14822169	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	1124478	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-382607	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-6334859	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14439562	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17211275	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26555680	usd
CY2023	us-gaap	Revenues Revenues	16523080	usd
CY2022	us-gaap	Revenues Revenues	24393946	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	19079436	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	21139794	usd
CY2023	us-gaap	Gross Profit GrossProfit	-2556356	usd
CY2022	us-gaap	Gross Profit GrossProfit	3254152	usd
CY2023	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	7178232	usd
CY2022	us-gaap	Compensation Expense Excluding Cost Of Good And Service Sold CompensationExpenseExcludingCostOfGoodAndServiceSold	5538352	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8348103	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4464836	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	5976445	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	713520	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	480934	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	22216300	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	10484122	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-24772656	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-7229970	usd
CY2023	us-gaap	Interest Expense InterestExpense	2608683	usd
CY2022	us-gaap	Interest Expense InterestExpense	336239	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	119	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	73821	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	623314	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	428411	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-25265	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1985250	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	140728	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-26757906	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7089242	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Profit Loss ProfitLoss	-26757906	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-7089242	usd
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-475373	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1229806	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-26282533	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-8319048	usd
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-34.03
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-34.03
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-12.48
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-12.48
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	772261	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	772261	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	666605	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	666605	shares
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21715789	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2838843	usd
CY2022	sgbx	Stock Issued During Period Value Restricted Stock Units Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockUnitsNetOfForfeitures		usd
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	49680	usd
CY2022	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	2976148	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-7089242	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14439562	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14439562	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3210631	usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	437325	usd
CY2023	sgbx	Stock Issued During Period Value Restricted Stock Units Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockUnitsNetOfForfeitures		usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	216250	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	354239	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	394735	usd
CY2023	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	46417	usd
CY2023	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	42716	usd
CY2023	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	684438	usd
CY2023	sgbx	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised		usd
CY2023	sgbx	Stock Issued During Period Value Conversion Of Accrued Interest StockIssuedDuringPeriodValueConversionOfAccruedInterest	45000	usd
CY2023	sgbx	Stock Issued During Period Value Conversion Of Short Term Notes Payable StockIssuedDuringPeriodValueConversionOfShortTermNotesPayable	730000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-6334859	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-26757906	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-7089242	usd
CY2023	us-gaap	Depreciation Depreciation	370525	usd
CY2022	us-gaap	Depreciation Depreciation	410314	usd
CY2023	us-gaap	Provision For Other Losses ProvisionForOtherLosses	1557534	usd
CY2022	us-gaap	Provision For Other Losses ProvisionForOtherLosses		usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	187640	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	164092	usd
CY2023	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	4418911	usd
CY2022	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges		usd
CY2023	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	40785	usd
CY2022	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	40785	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	990043	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	23726	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2433865	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	691227	usd
CY2023	sgbx	Accounts Receivable Write Offs AccountsReceivableWriteOffs		usd
CY2022	sgbx	Accounts Receivable Write Offs AccountsReceivableWriteOffs	1073531	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	491388	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	10526	usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	37397	usd
CY2023	sgbx	Issuance Of Subsidiary Stock IssuanceOfSubsidiaryStock	195000	usd
CY2022	sgbx	Issuance Of Subsidiary Stock IssuanceOfSubsidiaryStock		usd
CY2023	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	653575	usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	3210631	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	2798844	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-25265	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-606315	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-553132	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-25639	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-5532	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-309048	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-808265	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-171432	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	87932	usd
CY2023	us-gaap	Increase Decrease In Intangible Assets Current IncreaseDecreaseInIntangibleAssetsCurrent		usd
CY2022	us-gaap	Increase Decrease In Intangible Assets Current IncreaseDecreaseInIntangibleAssetsCurrent	-1139	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	5889741	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3519329	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	929727	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1000308	usd
CY2023	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent		usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-264450	usd
CY2023	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-5795	usd
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	176340	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-2859852	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-414674	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7141754	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5630614	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	607404	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2760032	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	93970	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	67832	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	760	usd
CY2023	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable		usd
CY2022	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	100000	usd
CY2023	sgbx	Payments For Project Development Costs PaymentsForProjectDevelopmentCosts	120781	usd
CY2022	sgbx	Payments For Project Development Costs PaymentsForProjectDevelopmentCosts	426194	usd
CY2023	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities		usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	500000	usd
CY2023	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	42662	usd
CY2022	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture		usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-864817	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3853298	usd
CY2023	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	10129078	usd
CY2022	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	500000	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	3704129	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2023	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	710692	usd
CY2022	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt		usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	394735	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023	sgbx	Finance Lease Payments FinanceLeasePayments		usd
CY2022	sgbx	Finance Lease Payments FinanceLeasePayments	431865	usd
CY2023	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	46417	usd
CY2022	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	2976148	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	42716	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	49680	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7441243	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2957693	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-565328	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-12441605	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	582776	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13024381	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17448	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	582776	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	271744	usd
CY2023	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred		usd
CY2022	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	3902175	usd
CY2023	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	730000	usd
CY2022	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1		usd
CY2023	sgbx	Common Stock Issued Conversion Of Accrued Interest CommonStockIssuedConversionOfAccruedInterest	45000	usd
CY2022	sgbx	Common Stock Issued Conversion Of Accrued Interest CommonStockIssuedConversionOfAccruedInterest		usd
CY2023	us-gaap	Contribution Of Property ContributionOfProperty	969188	usd
CY2022	us-gaap	Contribution Of Property ContributionOfProperty		usd
CY2023	sgbx	Restricted Stock Units Issued RestrictedStockUnitsIssued	30203	usd
CY2022	sgbx	Restricted Stock Units Issued RestrictedStockUnitsIssued		usd
CY2023	sgbx	Distribution To Subsidiary DistributionToSubsidiary	8220004	usd
CY2022	sgbx	Distribution To Subsidiary DistributionToSubsidiary		usd
CY2023	sgbx	Common Stock And Warrants Issued CommonStockAndWarrantsIssued	354329	usd
CY2022	sgbx	Common Stock And Warrants Issued CommonStockAndWarrantsIssued		usd
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4	segments
CY2023Q4	sgbx	Number Of Core Product Offerings NumberOfCoreProductOfferings	3	item
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17448	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1902332	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1902332	usd
CY2023	sgbx	Working Capital WorkingCapital	-15208831	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family: 'times new roman', times; font-size: 10pt;"> <div> <div style="border-left: none; border-right: none;"> <div style="border-left: none; border-right: none;"> <div> <div> <p style="color: #000000;font: 10pt 'Times New Roman', Times, serif;letter-spacing: normal;orphans: 2;text-indent: 0px;text-transform: none;white-space: normal;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;text-decoration-style: initial;text-decoration-color: initial;margin: 0pt 0px 0pt 0.5in;"><span style="font-family: 'times new roman', times; line-height: inherit;"><span style="color: black;"><b><i>Accounting estimates<span style="line-height: inherit;"> </span></i></b>– The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates, judgements and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period, together with amounts disclosed in the related notes to the financial statements. The Company's estimates used in these financial statements include, but are not limited to, revenue recognition, <span style="color: #000000; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; line-height: inherit; display: inline !important;">stock-based compensation, accounts receivable reserves, inventory valuations, goodwill, the valuation allowance related to the Company’s deferred tax assets, the carrying amount of intangible assets, right of use assets and the recoverability and useful lives of long-lived assets. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates.</span> </span></span></p> </div> </div> </div> </div> </div> </div>
CY2023	sgbx	Warranty Offered On Completed Contracts WarrantyOfferedOnCompletedContracts	P1Y
CY2023	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	0	usd
CY2022	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	11600000	usd
CY2023	sgbx	Number Of Primary Operating Segments Which Contributed Revenues Of Entity NumberOfPrimaryOperatingSegmentsWhichContributedRevenuesOfEntity	2	segments
CY2023	sgbx	Revenue At Point In Time RevenueAtPointInTime	0	usd
CY2022	sgbx	Revenue At Point In Time RevenueAtPointInTime	11641727	usd
CY2022	sgbx	Revenue Recognized Over Time RevenueRecognizedOverTime	12752219	usd
CY2023	sgbx	Total Construction Revenue Segment TotalConstructionRevenueSegment	16523080	usd
CY2023Q4	sgbx	Total Construction Revenue Segment Percentage TotalConstructionRevenueSegmentPercentage	1	pure
CY2022	sgbx	Total Construction Revenue Segment TotalConstructionRevenueSegment	12752219	usd
CY2022Q4	sgbx	Total Construction Revenue Segment Percentage TotalConstructionRevenueSegmentPercentage	0.52	pure
CY2023	sgbx	Total Medical Revenue Segment TotalMedicalRevenueSegment		usd
CY2023Q4	sgbx	Total Medical Revenue Segment Percentage TotalMedicalRevenueSegmentPercentage		pure
CY2022	sgbx	Total Medical Revenue Segment TotalMedicalRevenueSegment	11641727	usd
CY2022Q4	sgbx	Total Medical Revenue Segment Percentage TotalMedicalRevenueSegmentPercentage	0.48	pure
CY2023	sgbx	Revenue From Contract With Segments Customer Excluding Assessed Tax RevenueFromContractWithSegmentsCustomerExcludingAssessedTax	16523080	usd
CY2023	sgbx	Revenue From Contract With Segments Customer Excluding Assessed Tax Percentage RevenueFromContractWithSegmentsCustomerExcludingAssessedTaxPercentage	1	pure
CY2022	sgbx	Revenue From Contract With Segments Customer Excluding Assessed Tax RevenueFromContractWithSegmentsCustomerExcludingAssessedTax	24393946	usd
CY2022	sgbx	Revenue From Contract With Segments Customer Excluding Assessed Tax Percentage RevenueFromContractWithSegmentsCustomerExcludingAssessedTaxPercentage	1	pure
CY2023Q4	us-gaap	Deferred Costs And Other Assets DeferredCostsAndOtherAssets	102217	usd
CY2023Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	203926	usd
CY2023	sgbx	Accumulated Amortization Related To Deferred Costs AccumulatedAmortizationRelatedToDeferredCosts	173337	usd
CY2023	sgbx	Deferred Contract Costs Amortization Expense DeferredContractCostsAmortizationExpense	40785	usd
CY2022	sgbx	Deferred Contract Costs Amortization Expense DeferredContractCostsAmortizationExpense	40785	usd
CY2020Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	200000	shares
CY2023	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17448	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	582776	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	0	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	0	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1309330	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	us-gaap	Bankruptcy Proceedings Description Of Proceedings BankruptcyProceedingsDescriptionOfProceedings	Intangible assets consist of $2,766,000 of proprietary knowledge and technology, which is being amortized over 20 years. In addition, included in intangible assets is $68,344 of trademarks, and $238,422 of website costs that are being amortized over 5 years.
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	1880547	usd
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2852929	usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	187640	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	980963	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	164092	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1426202	usd
CY2021Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	3880762	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	637134	usd
CY2021Q2	sgbx	Project Development Costs ProjectDevelopmentCosts	824231	usd
CY2021Q2	sgbx	Project Development Costs Book Value ProjectDevelopmentCostsBookValue	4400361	usd
CY2023	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	450000	usd
CY2023	sgbx	Miscellaneous Income Included In Other Income MiscellaneousIncomeIncludedInOtherIncome	173314	usd
CY2022	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	150000	usd
CY2023	sgbx	Accounts Receivable From Lawsuit Settlement Written Off AccountsReceivableFromLawsuitSettlementWrittenOff	100000	usd
CY2023	sgbx	Accounts Payable Write Off AccountsPayableWriteOff	178000	usd
CY2023	sgbx	Accounts Payable Balance Settlement AccountsPayableBalanceSettlement	390000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="margin: 0pt 0pt 0pt 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; line-height: inherit;">Concentrations of credit risk </span><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; line-height: inherit;">–</span><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;"> Financial instruments, that potentially subject the Company to concentration of credit risk, consist principally of cash and cash equivalents. The Company places its cash with high credit quality institutions. At times, such amounts may be in excess of the FDIC insurance limits. The Company has not experienced any losses in such account and believes that it is not exposed to any significant credit risk on the account.</span></p> <p style="margin: 0pt 0pt 0pt 36pt; text-indent: 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;"> </span></p> <p style="margin: 0pt 0pt 0pt 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;"><span style="font-family: 'times new roman', times; line-height: inherit;">With respect to receivables, concentrations of credit risk are limited to a few customers in the construction industry. The Company performs ongoing credit evaluations of its customers’ financial condition and, generally, requires no collateral from its customers other than normal lien rights. At <span>December 31, 2023</span> and </span><span>2022</span><span style="font-family: 'times new roman', times; line-height: inherit;">, </span>100<span style="font-family: 'times new roman', times; line-height: inherit;">% and </span>80<span style="font-family: 'times new roman', times; line-height: inherit;">%, respectively, of the Company’s gross accounts receivable were due from </span>three<span style="font-family: 'times new roman', times; line-height: inherit;"> and four customers</span>.</span></p> <p style="margin: 0pt; text-indent: 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;"> </span></p> <p style="margin: 0pt 0pt 0pt 36pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;"><span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">Revenue in excess of<span style="line-height: inherit;"> </span></span>10<span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">% relating to</span><span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;"><span style="line-height: inherit;"> one</span></span><span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;"><span style="line-height: inherit;"> </span>customer represented approximately<span style="line-height: inherit;"> 87</span></span><span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">% and<span style="line-height: inherit;"> 65</span></span><span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">% of the Company's total revenue for the year ended <span>December 31, 2023</span> and <span>2022</span>, respectively. </span></span></p> <p style="margin: 0pt 0pt 0pt 36pt;"><br/></p> <p style="margin: 0pt 0pt 0pt 36pt;"><span style="background-color: #ffffff; line-height: inherit;"><span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; background-color: #ffffff; line-height: inherit;">For the year ending <span>December 31, 2023</span> and <span>2022</span>, there were no vendors that represented 10% or more of our cost of revenue.</span></span><span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;"> </span><span style="color: #000000; font-family: 'times new roman', times; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; line-height: inherit;">The Company believes it has access to alternative suppliers, with limited disruption to the business, should circumstances change with its existing suppliers.</span><span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span></p>
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	819887	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	145746	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	963116	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	182753	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1280456	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2917646	usd
CY2023Q4	sgbx	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	20213733	usd
CY2022Q4	sgbx	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	13730177	usd
CY2021Q4	sgbx	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	4272425	usd
CY2023Q4	sgbx	Provision For Loss On Uncompleted Contracts ProvisionForLossOnUncompletedContracts		usd
CY2022Q4	sgbx	Provision For Loss On Uncompleted Contracts ProvisionForLossOnUncompletedContracts		usd
CY2021Q4	sgbx	Provision For Loss On Uncompleted Contracts ProvisionForLossOnUncompletedContracts	2238578	usd
CY2023Q4	sgbx	Estimated Income Loss On Uncompleted Contracts EstimatedIncomeLossOnUncompletedContracts	968040	usd
CY2022Q4	sgbx	Estimated Income Loss On Uncompleted Contracts EstimatedIncomeLossOnUncompletedContracts	2160085	usd
CY2021Q4	sgbx	Estimated Income Loss On Uncompleted Contracts EstimatedIncomeLossOnUncompletedContracts	3156377	usd
CY2023Q4	sgbx	Contract Receivables Retainage ContractReceivablesRetainage	19245693	usd
CY2022Q4	sgbx	Contract Receivables Retainage ContractReceivablesRetainage	11570092	usd
CY2021Q4	sgbx	Contract Receivables Retainage ContractReceivablesRetainage	3354626	usd
CY2023Q4	sgbx	Costs In Excess Of Billings To Date CostsInExcessOfBillingsToDate	20601946	usd
CY2022Q4	sgbx	Costs In Excess Of Billings To Date CostsInExcessOfBillingsToDate	11970979	usd
CY2021Q4	sgbx	Costs In Excess Of Billings To Date CostsInExcessOfBillingsToDate	4750289	usd
CY2023Q4	sgbx	Net Contract Liabilities On Uncompleted Contracts NetContractLiabilitiesOnUncompletedContracts	-1356253	usd
CY2022Q4	sgbx	Net Contract Liabilities On Uncompleted Contracts NetContractLiabilitiesOnUncompletedContracts	-400887	usd
CY2021Q4	sgbx	Net Contract Liabilities On Uncompleted Contracts NetContractLiabilitiesOnUncompletedContracts	-1395663	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	10745	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	36384	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	41916	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1366998	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	437271	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1437579	usd
CY2023Q4	sgbx	Contract With Customer Asset Liability ContractWithCustomerAssetLiability	-1356253	usd
CY2022Q4	sgbx	Contract With Customer Asset Liability ContractWithCustomerAssetLiability	-400887	usd
CY2021Q4	sgbx	Contract With Customer Asset Liability ContractWithCustomerAssetLiability	-1395663	usd
CY2023Q4	sgbx	Project Development Costs Non Current ProjectDevelopmentCostsNonCurrent	409495	usd
CY2023Q4	sgbx	Security Deposits Non Current SecurityDepositsNonCurrent	194832	usd
CY2022Q4	sgbx	Project Development Costs Non Current ProjectDevelopmentCostsNonCurrent	289984	usd
CY2022Q4	sgbx	Security Deposits Non Current SecurityDepositsNonCurrent	193562	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6093423	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6327629	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	511022	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	718726	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5582401	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5608903	usd
CY2023	us-gaap	Depreciation Depreciation	370525	usd
CY2022	us-gaap	Depreciation Depreciation	410314	usd
CY2023	us-gaap	Interest Income Other InterestIncomeOther	0	usd
CY2022	us-gaap	Interest Income Other InterestIncomeOther	37397	usd
CY2023	us-gaap	Debt Securities Held To Maturity Allowance For Credit Loss Writeoff DebtSecuritiesHeldToMaturityAllowanceForCreditLossWriteoff	750000	usd
CY2023	us-gaap	Debt Securities Held To Maturity Accrued Interest Writeoff DebtSecuritiesHeldToMaturityAccruedInterestWriteoff	129418	usd
CY2023Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	6467854	usd
CY2022Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	3147014	usd
CY2023Q4	sgbx	Accrued Public Fees AccruedPublicFees	150474	usd
CY2022Q4	sgbx	Accrued Public Fees AccruedPublicFees	178491	usd
CY2023Q4	sgbx	Accrued General And Administrative AccruedGeneralAndAdministrative	971124	usd
CY2022Q4	sgbx	Accrued General And Administrative AccruedGeneralAndAdministrative	254557	usd
CY2023Q4	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	1349043	usd
CY2022Q4	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	349777	usd
CY2023Q4	sgbx	Accrued Interest AccruedInterest	44038	usd
CY2022Q4	sgbx	Accrued Interest AccruedInterest	10923	usd
CY2023Q4	sgbx	Accrued Losses On Construction Services Current And Non Current AccruedLossesOnConstructionServicesCurrentAndNonCurrent	871730	usd
CY2022Q4	sgbx	Accrued Losses On Construction Services Current And Non Current AccruedLossesOnConstructionServicesCurrentAndNonCurrent		usd
CY2023Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent		usd
CY2022Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	68760	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	9854263	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	4009522	usd
CY2021Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	2000000	usd
CY2021Q3	us-gaap	Proceeds From Construction Loans Payable ProceedsFromConstructionLoansPayable	1948234	usd
CY2021Q3	us-gaap	Debt Instrument Term DebtInstrumentTerm	P1Y
CY2021Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.12	pure
CY2021Q3	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.005	pure
CY2023	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	0	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	0	usd
CY2022	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	20000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	4134	usd
CY2022Q3	us-gaap	Proceeds From Subordinated Short Term Debt ProceedsFromSubordinatedShortTermDebt	500000	usd
CY2021Q4	sgbx	Value Of Renovation Improvements ValueOfRenovationImprovements	750000	usd
CY2021Q4	sgbx	Principal Amount Of Promissory Note PrincipalAmountOfPromissoryNote	750000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	11814717	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3478300	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	895222	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	80000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	10919495	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	3398300	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	8472080	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	2648300	usd
CY2023Q4	us-gaap	Other Loans Payable Long Term OtherLoansPayableLongTerm	2447415	usd
CY2022Q4	us-gaap	Other Loans Payable Long Term OtherLoansPayableLongTerm	750000	usd
CY2020Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	1059600	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	0	usd
CY2023	us-gaap	Lessor Direct Financing Lease Description LessorDirectFinancingLeaseDescription	The leases have remaining lease terms ranging from one year to ten years.
CY2023Q4	sgbx	Operating Lease Right Of Use Assets OperatingLeaseRightOfUseAssets	551702	usd
CY2023Q4	sgbx	Operating Lease Liabilities Current OperatingLeaseLiabilitiesCurrent	146753	usd
CY2023Q4	sgbx	Operating Lease Liabilities Noncurrent OperatingLeaseLiabilitiesNoncurrent	404949	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	551702	usd
CY2023Q4	sgbx	Right Of Use Assets Finance Leases RightOfUseAssetsFinanceLeases	1435435	usd
CY2023Q4	sgbx	Lease Liability Current Maturities LeaseLiabilityCurrentMaturities	709335	usd
CY2023Q4	sgbx	Lease Liability Non Current Liabilities LeaseLiabilityNonCurrentLiabilities	144342	usd
CY2023Q4	sgbx	Total Finance Lease Liabilities TotalFinanceLeaseLiabilities	853677	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y9M
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.03	pure
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.03	pure
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	324000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	801869	usd
CY2023Q4	sgbx	Lease Liability Payments Due Next Twelve Months LeaseLiabilityPaymentsDueNextTwelveMonths	1125869	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	243000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	66822	usd
CY2023Q4	sgbx	Lease Liability Payments Due Year Two LeaseLiabilityPaymentsDueYearTwo	309822	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	567000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	868691	usd
CY2023Q4	sgbx	Lease Liability Payments Due LeaseLiabilityPaymentsDue	1435691	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	15298	usd
CY2023Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	15014	usd
CY2023Q4	sgbx	Lease Liability Undiscounted Excess Amount LeaseLiabilityUndiscountedExcessAmount	30312	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	551702	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	853677	usd
CY2023Q4	sgbx	Present Value Of Lease Liabilities PresentValueOfLeaseLiabilities	1405379	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	943441	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	770272	usd
CY2022Q4	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	6810762	usd
CY2021Q4	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	3217909	usd
CY2023	sgbx	New Contracts Received During Year NewContractsReceivedDuringYear	11614650	usd
CY2022	sgbx	New Contracts Received During Year NewContractsReceivedDuringYear	13803733	usd
CY2023	sgbx	Adjustments And Cancellations Net AdjustmentsAndCancellationsNet		usd
CY2022	sgbx	Adjustments And Cancellations Net AdjustmentsAndCancellationsNet	1086301	usd
CY2023	sgbx	Construction Backlog Gross ConstructionBacklogGross	18425412	usd
CY2022	sgbx	Construction Backlog Gross ConstructionBacklogGross	18107943	usd
CY2023	sgbx	Contract Revenue ContractRevenue	16523080	usd
CY2022	sgbx	Contract Revenue ContractRevenue	11297181	usd
CY2023Q4	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	1902332	usd
CY2022Q4	sgbx	Construction Contracts Backlog ConstructionContractsBacklog	6810762	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1902332	usd
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segments
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-5567459	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1600538	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	35157	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-688620	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-5532302	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2289158	usd
CY2023	sgbx	Provision Income Tax Expense Benefit ProvisionIncomeTaxExpenseBenefit	-5532302	usd
CY2022	sgbx	Provision Income Tax Expense Benefit ProvisionIncomeTaxExpenseBenefit	-2289158	usd
CY2023	sgbx	Amount Of Valuation Reserve AmountOfValuationReserve	-5532302	usd
CY2022	sgbx	Amount Of Valuation Reserve AmountOfValuationReserve	-2289158	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.039	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.039	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.249	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.249	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	12138836	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	8155944	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	34338	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	37734	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	2605215	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	2031628	usd
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	305516	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	-467395	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-181016	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-165336	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	296808	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	74801	usd
CY2023Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	194	usd
CY2022Q4	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	213	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	15199891	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	9667589	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	15199891	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9667589	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	2289158	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	0	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	1	pure
CY2023Q4	sgbx	Future Taxable Income Temporarily Removes Percentage FutureTaxableIncomeTemporarilyRemovesPercentage	0	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements EffectiveIncomeTaxRateReconciliationTaxSettlements	0	pure
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2021Q4	sgbx	Gross Proceeds GrossProceeds	11550000	usd
CY2021Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	10500000	usd
CY2023	sgbx	Common Stock And Warrants Issued CommonStockAndWarrantsIssued	354329	usd
CY2023	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	46417	usd
CY2023	sgbx	Stock Issued During Period Value Conversion Of Short Term Notes Payable StockIssuedDuringPeriodValueConversionOfShortTermNotesPayable	730000	usd
CY2023	sgbx	Stock Issued During Period Value Conversion Of Accrued Interest StockIssuedDuringPeriodValueConversionOfAccruedInterest	45000	usd
CY2023Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	0	shares
CY2023	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	3210631	usd
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	2798844	usd
CY2023	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	3210631	usd
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	2798844	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	0	usd
CY2023Q4	us-gaap	Share Price SharePrice	0
CY2023Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	0	usd
CY2019Q1	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	2100000	usd
CY2018Q3	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	761401.66	usd
CY2020Q1	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	2861401.66	usd

Files In Submission

Name	View Source	Status
0001213900-24-040541-index-headers.html	Edgar Link	pending
0001213900-24-040541-index.html	Edgar Link	pending
0001213900-24-040541.txt	Edgar Link	pending
0001213900-24-040541-xbrl.zip	Edgar Link	pending
ex211_2.htm	Edgar Link	pending
ex231_3.htm	Edgar Link	pending
ex311_4.htm	Edgar Link	pending
ex312_5.htm	Edgar Link	pending
ex321_6.htm	Edgar Link	pending
ex49_1.htm	Edgar Link	pending
ex971_7.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
report.css	Edgar Link	pending
sgbx-20231231.htm	Edgar Link	pending
sgbx-20231231.xsd	Edgar Link	pending
Show.js	Edgar Link	pending
sgbx-20231231_def.xml	Edgar Link	unprocessable
sgbx-20231231_lab.xml	Edgar Link	unprocessable
sgbx-20231231_pre.xml	Edgar Link	unprocessable
sgbx-20231231_htm.xml	Edgar Link	completed
sgbx-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SGBX
SAFE & GREEN HOLDINGS CORP. Stock $sgbx

2024 Q2 Form 10-K Financial Statement

#000121390024040541 Filed on May 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGBX SAFE & GREEN HOLDINGS CORP. Stock $sgbx

2024 Q2 Form 10-K Financial Statement

#000121390024040541 Filed on May 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGBX
SAFE & GREEN HOLDINGS CORP. Stock $sgbx